Process View
The process of regulating the proliferation and elimination of B cells such that the total number of B cells within a whole or part of an organism is stable over time in the absence of an outside stimulus.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "b cell homeostasis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.968 | Mouse | |
| BCL2L1 | BCL2-like 1 | 0.919 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.854 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.656 | Mouse | |
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.625 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.564 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.405 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.366 | ||
| HDAC9 | histone deacetylase 9 | 0.343 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.279 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.264 | ||
| MSN | moesin | 0.243 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.237 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.218 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.210 | ||
| PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.209 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.192 | ||
| BAX | BCL2-associated X protein | 0.179 | Mouse | |
| CARD11 | caspase recruitment domain family, member 11 | 0.178 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.139 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.133 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.113 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.109 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.104 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.101 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.100 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.098 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.092 | ||
| BID | BH3 interacting domain death agonist | 0.091 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.076 | Mouse | |
| BAD | BCL2-associated agonist of cell death | 0.067 | ||
| C9orf89 | chromosome 9 open reading frame 89 | 0.064 | ||
| EP300 | E1A binding protein p300 | 0.062 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.057 | ||
| LAT | linker for activation of T cells | 0.056 | ||
| TRAF6 | TNF receptor-associated factor 6 | 0.055 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.053 | ||
| RNF144B | ring finger protein 144B | 0.053 | ||
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.050 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.048 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.047 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.044 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.040 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.039 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.037 | Mouse | |
| MAPK12 | mitogen-activated protein kinase 12 | 0.036 | ||
| TNIP1 | TNFAIP3 interacting protein 1 | 0.036 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.035 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.035 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.034 | ||
| ZNF282 | zinc finger protein 282 | 0.032 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.032 | ||
| LAPTM5 | lysosomal protein transmembrane 5 | 0.032 | ||
| BCL10 | B-cell CLL/lymphoma 10 | 0.030 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.030 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.025 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.025 | ||
| ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 | 0.025 | ||
| TNF | tumor necrosis factor | 0.025 | ||
| RNR2 | l-rRNA | 0.024 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.024 | ||
| BCL2L2 | BCL2-like 2 | 0.023 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.023 | Mouse | |
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.023 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.023 | ||
| IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 0.022 | ||
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.022 | ||
| EZR | ezrin | 0.022 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.021 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.021 | ||
| CASP6 | caspase 6, apoptosis-related cysteine peptidase | 0.021 | ||
| ARNTL | aryl hydrocarbon receptor nuclear translocator-like | 0.021 | ||
| DUSP6 | dual specificity phosphatase 6 | 0.021 | ||
| SPRR2D | small proline-rich protein 2D | 0.020 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.019 | ||
| KRT17 | keratin 17 | 0.019 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.019 | ||
| FLNA | filamin A, alpha | 0.019 | ||
| BRAP | BRCA1 associated protein | 0.018 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.018 | ||
| AKT3 | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | 0.018 | ||
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.018 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.017 | ||
| SQSTM1 | sequestosome 1 | 0.016 | ||
| MEF2A | myocyte enhancer factor 2A | 0.016 | ||
| CCDC85B | coiled-coil domain containing 85B | 0.016 | ||
| TCF4 | transcription factor 4 | 0.016 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.016 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.016 | ||
| AMBRA1 | autophagy/beclin-1 regulator 1 | 0.016 | ||
| INSR | insulin receptor | 0.015 | ||
| PURA | purine-rich element binding protein A | 0.015 | ||
| CUX1 | cut-like homeobox 1 | 0.015 | ||
| PYCARD | PYD and CARD domain containing | 0.015 | ||
| STK17B | serine/threonine kinase 17b | 0.015 | ||
| SLC7A11 | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | 0.014 | ||
| CD83 | CD83 molecule | 0.014 | ||
| AHR | aryl hydrocarbon receptor | 0.014 | Mouse | |
| ADAM15 | ADAM metallopeptidase domain 15 | 0.013 | ||
| FKBP8 | FK506 binding protein 8, 38kDa | 0.013 | ||
| BCL2A1 | BCL2-related protein A1 | 0.013 | Mouse | |
| BIRC2 | baculoviral IAP repeat containing 2 | 0.013 | ||
| ATF2 | activating transcription factor 2 | 0.012 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.012 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.012 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.012 | ||
| CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0.012 | ||
| STK10 | serine/threonine kinase 10 | 0.012 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.012 | ||
| C19orf25 | chromosome 19 open reading frame 25 | 0.012 | ||
| DIABLO | diablo, IAP-binding mitochondrial protein | 0.012 | ||
| NEB | nebulin | 0.012 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.012 | Mouse | |
| REPS2 | RALBP1 associated Eps domain containing 2 | 0.012 | ||
| IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 0.012 | ||
| VEGFB | vascular endothelial growth factor B | 0.012 | ||
| AXL | AXL receptor tyrosine kinase | 0.011 | ||
| IRF3 | interferon regulatory factor 3 | 0.011 | ||
| SLC3A2 | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 | 0.011 | ||
| CREB1 | cAMP responsive element binding protein 1 | 0.011 | ||
| ITSN2 | intersectin 2 | 0.011 | ||
| AIP | aryl hydrocarbon receptor interacting protein | 0.011 | ||
| RB1 | retinoblastoma 1 | 0.011 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.011 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.011 | ||
| NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 | 0.010 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.010 | ||
| MAVS | mitochondrial antiviral signaling protein | 0.010 | ||
| BBC3 | BCL2 binding component 3 | 0.010 | ||
| CCDC67 | coiled-coil domain containing 67 | 0.010 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.010 | ||
| ATM | ataxia telangiectasia mutated | 0.010 | ||
| TICAM1 | toll-like receptor adaptor molecule 1 | 0.010 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.010 | ||
| SPTBN1 | spectrin, beta, non-erythrocytic 1 | 0.010 |